Market Cap (In INR)
83.19 Billion
Revenue (In INR)
19.42 Billion
Net Income (In INR)
3.05 Billion
Avg. Volume
825.17 Thousand
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 378.8-658.85
- PE
- -
- EPS
- -
- Beta Value
- 0.28
- ISIN
- INE258B01022
- CUSIP
- Y2477C130
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Ameya Ashok Chandavarkar
- Employee Count
- -
- Website
- https://www.fdcindia.com
- Ipo Date
- 2002-07-01
- Details
- FDC Limited manufactures and markets pharmaceutical products in India and internationally. The company offers specialized formulations for various therapeutic segments, including anti-infective, gastrointestinal, ophthalmological, vitamins/minerals/dietary supplements, cardiac, anti-diabetes, respiratory, gynecology, dermatology, analgesics, and others; and oral rehydration salts. It provides specialized formulations primarily under the Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl, and Mycoderm brand names. The company also offers anti-oxidants, balanced energy drinks, and vitamins and nutraceuticals under the Enerzal, Humyl, Mum Mum 1, Prosoyal, Simyl-LBW, Simyl-MCT, and Zefrich brands. In addition, it provides various active pharmaceutical ingredients. FDC Limited was founded in 1936 and is headquartered in Mumbai, India.
More Stocks
-
S&J
-
DOPPLERDoppler S.A.
DOPPLER
-
RSGK
-
RIOFFRio2 Limited
RIOFF
-
DLTA
-
SAIL
-
TPA
-
GENC